Italy’s Chiesi acquires AMYT for_$14.50/sh_cash +CVR: https://www.globenewswire.com/news-release/2023/01/08/2584741/0/en/Chiesi-Farmaceutici-S-p-A-to-Acquire-Amryt-Pharma-Plc.html Excluding the CVR, the buyout premium is a 107% premium to Friday’s closing price. The nominal deal value (sans CVR) is $1.25B.